New patent for Janssen Pharms drug INVOKAMET

March 15, 2023 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from two suppliers. There are five patents…

The post New patent for Janssen Pharms drug INVOKAMET appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.